Glatt Air Techniques is dedicated to the development of solid, oral dosage forms from pre-formulation studies through commercial scale, GMP production.
Symyx Technologies enables companies in life sciences to transform scientific R&D and achieve extraordinary breakthroughs in productivity and return on investment through expertise in scientific information management, microscale parallel experimentation, and contract research.
AstraZeneca announced that the FDA has approved SYMBICORT (budesonide/formoterol fumarate dihydrate).
The human immunodeficiency virus (HIV) adapts so well to the body's defense system that any successful AIDS vaccine must keep pace with the ever-changing immunological profile of the virus.
Mayo Clinic researchers have shown that patients who were taking statins before a stroke experienced better outcomes and recovery than patients who weren't on the drug.
A marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading.
Amicus Therapeutics announced that it has suspended enrollment for the Phase 2 clinical trial of its investigational drug AT2220.
Using a novel approach that combines a statistical tool that identifies genes interacting on the same biological pathways with highly automated gene-hunting techniques that scan the whole genome, an international team of researchers has discovered new genes involved in Crohn's disease.
A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating drug resistant tuberculosis (XDR-TB).
The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis.
Endo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.
The discovery of the molecule, an antibody known as CR6261, is good news for researchers who hope to design a flu vaccine that would give humans lifelong protection against a majority of influenza viruses.
President Barack Obama's budget aims to foster generic competition for costly biotech drugs used to treat cancer and other intractable ailments.
Abbott announced that it has completed its acquisition of Advanced Medical Optics.
Federal health officials are adding their sternest warning to a heartburn drug that has been linked to muscle spasms.